Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance Elastography Score Reflecting Hepatic Fibrosis as an Independent Predictor for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy

NCT01447667 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01447667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01447667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance Elastography Score Reflecting Hepatic Fibrosis as an Independent Predictor for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2022
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic fibrosis, hepatocellular carcinoma